Results 21 to 30 of about 9,378,676 (283)
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison +3 more
doaj +1 more source
Current status and challenges of meningococcal vaccines development in China
Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
Epidemiology of invasive meningococcal disease, Japan, 2013 to 2023. [PDF]
Kobayashi M +6 more
europepmc +2 more sources
Importance A 4-component meningococcus group B vaccine (4CMenB) is the only vaccine in use to prevent group B invasive meningococcal disease in young children, but no matched controlled studies have evaluated it.
F. Rodrigues +5 more
semanticscholar +1 more source
Background: Since 2009, the incidence of meningococcal serogroup W disease has increased rapidly in the UK because of a single strain (the so-called original UK strain) belonging to the hypervirulent sequence type-11 clonal complex (cc11), with a variant
Dr Mirjam J Knol, PhD +9 more
doaj +1 more source
Imaging of disease dynamics during meningococcal sepsis. [PDF]
Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development
Hong Sjölinder, Ann-Beth Jonsson
doaj +1 more source
SINAVE’s quality: completeness for Meningococcal Disease – Northern Portugal, 2020-2022 [PDF]
Alírio E. Rodrigues +5 more
europepmc +3 more sources
Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008. [PDF]
BackgroundAlthough human immunodeficiency virus (HIV) infection is an established risk factor for several bacterial infections, the association between HIV infection and meningococcal disease remains unclear.MethodsExpanded chart reviews were completed ...
Clark, Thomas A +17 more
core +2 more sources
Invasive meningococcal disease [PDF]
Invasive meningococcal disease (IMD) is a major public health and continues to cause substantial mortality and morbidity. Serotype C is the most frequent in Brazil. The clinical spectrum of IMD is broad (meningitis, meningococcemia or both) and the clinical evolution may be unpredictable.
Strelow, Vanessa L., Vidal, Jose E.
openaire +5 more sources
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
M. Taha, A. Deghmane
semanticscholar +1 more source

